<DOC>
	<DOCNO>NCT01578642</DOCNO>
	<brief_summary>The EndoStim Stimulation System investigational device intend improve low esophageal sphincter ( LES ) rest tone restore LES function individual suffer gastroesophageal reflux disease ( GERD ) .</brief_summary>
	<brief_title>Feasibility Study Evaluating Effect Electrical Stimulation Lower Esophageal Sphincter Pressure Esophageal Acid Exposure Patients With Gastroesophageal Reflux Disease</brief_title>
	<detailed_description>EndoStim develop investigational medical device specifically design deliver electrical stimulation LES complete two clinical feasibility study use EndoStim stimulation system fifteen subject . Acute electrical stimulation result significant LES pressure adverse effect report . Results study promise warrant additional clinical study evaluate effectiveness EndoStim stimulation system treat GERD time . In study , EndoStim propose use fully implantable system . Results study expect provide confirmation safety long-term LES stimulation may provide long term clinical benefit GERD patient .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Subject 21 65 year age . Subject history heartburn , regurgitation &gt; 6 month prompt physician recommendation continual daily use PPI study entry . Baseline GERDHRQL heartburn score ≥ 20 PPI assess runin phase . Subject American Society Anesthesiologists ( ASA ) Physical Status Classification I II ( comparable local classification ) . Subject demonstrate satisfactory symptomatic response previous course GERD therapy ( ≥ 2 week ) ; GERD HRQL heartburn score improvement ≥ 10 therapy assess run phase . Subject exhibit excessive low esophageal acid exposure 24hour pHmetry antisecretory therapy perform within 6 month enrollment ; pH &lt; 4 &gt; 5 % total &gt; 3 % supine time . Subject rest LES end expiratory pressure &gt; 5mm Hg &lt; 15 mm Hg high resolution manometry within 6 month enrollment . Subject esophagitis ≤ Grade C ( LA classification ) upper endoscopy within 6 month enrollment . Subject esophageal body contraction amplitude &gt; 30 mmHg &gt; 70 % swallow &gt; 50 % peristaltic contraction high resolution manometry . Subject sign informed consent form . Subject nonGERD esophageal motility disorder . Subject gastroparesis . Subject significant multisystem disease . Subject scleroderma require therapy precede 2 year . Subject dermatomyositis require therapy precede 2 year . Subject CalcinosisRaynaud'sesophaguschlerodactyly syndrome require therapy precede 2 year . Subject Sjogren 's Syndrome require therapy precede 2 year . Subject Sharp 's Syndrome require therapy precede 2 year . Subject persistent esophagitis great LA grade C. Subject Barrett 's epithelium ( &gt; M2 ; &gt; C1 ) dysplasia . Subject hiatus hernia large 3 cm . Subject body mass Index great 35 kg/m2 . Subject Type 1 diabetes mellitus Subject uncontrolled Type 2 diabetes mellitus ( T2DM ) define HbA1c &gt; 9.5 previous 6 month , T2DM &gt; 10 year . Subject autoimmune disorder require therapy precede 2 year . Subject suspect confirmed esophageal gastric cancer . Subject esophageal gastric varix . Subject significant cardiac arrhythmia ectopy significant cardiovascular disease . Subject exist implanted electrical stimulator ( e.g. , pacemaker ) . Subject require chronic anticoagulant therapy . Subject dysphagia esophageal peptic structure , exclude Schatzki 's ring . Subject pregnant intend become pregnant trial period . Subject currently enrol potentially confound research . Subject condition , discretion investigator , would preclude participation trial . History malignancy last 2 year History previous esophageal gastric surgery , include nissen fundoplication</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>GERD</keyword>
	<keyword>LES Pressure</keyword>
	<keyword>Electrical Stimulation</keyword>
</DOC>